Companies / Agios Pharmaceuticals, Inc. / Activity
Activity — Agios Pharmaceuticals, Inc.
106 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +6K +16.28% | 40,459 0.07% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +3K +63.52% | 6,938 0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +2K +97.22% | 4,970 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +2K +249.20% | 3,293 <0.01% of shares | low |
| Jan 5, 2026 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +8K +29.03% | 37,665 0.06% of shares | low |
| Dec 30, 2025 | Burns James William Executive | Exercise | Common stock | $0 | +6K +20.94% | 34,650 0.06% of shares | low |
| Dec 30, 2025 | Gheuens Sarah Executive | Exercise | Common stock | $0 | +6K +9.72% | 67,727 0.11% of shares | low |
| Dec 30, 2025 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +6K +22.97% | 32,122 0.05% of shares | low |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Grant | Stock options (right to buy) | — | +15K | 14,950 0.03% of shares | low |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Grant | Restricted stock units | — | +3K | 2,927 <0.01% of shares | low |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Exercise | Restricted stock units | — | -3K -100.00% | 0 0.00% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Grant | Stock options (right to buy) | — | +15K | 14,950 0.03% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Grant | Restricted stock units | — | +3K | 2,927 <0.01% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Exercise | Restricted stock units | — | -3K -100.00% | 0 0.00% of shares | low |
| Jun 13, 2026 | Capello Jeffrey D Director | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -5K -33.33% | 10,607 0.02% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Jones Cecilia Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Jones Cecilia Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Dec 30, 2025 | Jones Cecilia Executive | Exercise | Performance share units | — | -6K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -13K -33.33% | 26,000 0.04% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -18K -50.00% | 18,000 0.03% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -9K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Goff Brian CEO | Grant | Stock options (right to buy) | — | +174K | 174,000 0.29% of shares | low |
| Mar 1, 2026 | Goff Brian CEO | Grant | Restricted stock units | — | +48K | 48,000 0.08% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Performance share units | — | -13K -100.00% | 0 0.00% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Performance share units | — | -26K -50.00% | 25,528 0.04% of shares | low |
| Mar 5, 2026 | Viswanadhan Krishnan Executive | Exercise | Restricted stock units | — | -8K -33.33% | 16,200 0.03% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -33.34% | 7,839 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Burns James William Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Burns James William Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Restricted stock units | — | +22K | 22,000 0.04% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 1, 2026 | Milanova Tsveta Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Milanova Tsveta Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -3K -33.33% | 5,390 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -2K -50.00% | 2,450 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Washburn Theodore James Jr. Executive | Grant | Restricted stock units | — | +8K | 8,452 0.01% of shares | low |